MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 6, 2005; DOI: 10.1124/mol.105.011882


0026-895X/05/6803-787-792$20.00
Mol Pharmacol 68:787-792, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.011882v1
68/3/787    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baur, R.
Right arrow Articles by Sigel, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baur, R.
Right arrow Articles by Sigel, E.

Novel Plant Substances Acting as {beta} Subunit Isoform-Selective Positive Allosteric Modulators of GABAA Receptors

Roland Baur, Urs Simmen, Martin Senn, Urs Séquin, and Erwin Sigel

Department of Pharmacology, University of Bern, Bern, Switzerland (R.B., E.S.); and Departments of Pharmacy (U.Si.) and Chemistry (M.S., U.Sé.), University of Basel, Basel, Switzerland

GABAA receptors are modulated by a large variety of compounds. A common chemical characteristic of most of these modulators is that they contain a cyclic entity. Three linear molecules of a polyacetylene structure were isolated from the East African medicinal plant Cussonia zimmermannii Harms and shown to allosterically stimulate GABAA receptors. Stimulation was not abolished by the absence of the {gamma}2 subunit, the benzodiazepine antagonist Ro15-1788 (8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester), or the point mutation {beta}2N265S that abolishes effects by loreclezole. At a concentration of 30 µM, the substances by themselves elicited only tiny currents. Maximal stimulation at {alpha}1{beta}2{gamma}2 amounted to 110 to 450% for the three substances, and half-maximal stimulation was observed at concentrations of 1 to 2 µM. Stimulation was subunit composition-dependent and was for the substance MS-1, {alpha}1{beta}2{gamma}2 {approx} {alpha}1{beta}2 {approx} {alpha}3{beta}2{gamma}2 > {alpha}2{beta}2{gamma}2 > {alpha}5{beta}2{gamma}2 {approx} {alpha}1{beta}3{gamma}2 {approx} {alpha}6{beta}2{gamma}2 > {alpha}1{beta}1{gamma}2, for MS-2 {alpha}1{beta}2{gamma}2 {approx} {alpha}3{beta}2{gamma}2 {approx} {alpha}1{beta}2 > {alpha}2{beta}2{gamma}2 {approx} {alpha}6{beta}2{gamma}2 {approx} {alpha}5{beta}2{gamma}2 > {alpha}1{beta}1{gamma}2, and for MS-4, {alpha}1{beta}2{gamma}2 {approx} {alpha}1{beta}2 {approx} {alpha}5{beta}2{gamma}2 {approx} {alpha}3{beta}2{gamma}2 {approx} {alpha}2{beta}2{gamma}2 > {alpha}6{beta}2{gamma}2 >> {alpha}1{beta}1{gamma}2. Maximal stimulation by MS-1 was 450% at {alpha}1{beta}2{gamma}2, 80% at {alpha}1{beta}1{gamma}2, and 150% at {alpha}1{beta}3{gamma}2. MS-1 was thus specific for receptors containing the {beta}2 subunit. The reversal potential was unaffected by 10 µM MS-1, whereas apparent picrotoxin affinity for current inhibition was increased approximately 3-fold. In summary, these positive allosteric modulators of GABAA receptors of plant origin have a novel unusual chemical structure and act at a site independent of that of benzodiazepines and loreclezole.


Received February 8, 2005; accepted June 6, 2005

Address correspondence to: Dr. Erwin Sigel, Department of Pharmacology, Friedbuehlstrasse 49, CH-3010 Bern, Switzerland. E-mail: erwin.sigel{at}pki.unibe.ch







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics